MDB Capital Group and Aegis Capital will assist with public offering
By Devika Patel
Knoxville, Tenn., Feb. 8 - Imprimis Pharmaceuticals, Inc. priced a $9.66 million public sale of stock with a $1.45 million greenshoe, according to an 8-K filed Friday with the Securities and Exchange Commission.
The company will sell 1.84 million common shares at $5.25 apiece. The price per share is a 34.38% discount to the Feb. 7 closing share price of $8.00.
Settlement is expected Feb. 13.
MDB Capital Group, LLC is the bookrunning manager.
The specialty pharmaceutical company is based in La Jolla, Calif.
| Issuer: | Imprimis Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $9.66 million
|
| Greenshoe: | $1,449,000
|
| Shares: | 1.84 million
|
| Price: | $5.25
|
| Warrants: | No
|
| Bookrunner: | MDB Capital Group, LLC
|
| Co-manager: | Aegis Capital Corp.
|
| Pricing date: | Feb. 8
|
| Settlement date: | Feb. 13
|
| Stock symbol: | OTCBB: IMMY
|
| Stock price: | $8.00 at close Feb. 7
|
| Market capitalization: | $33.52 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
